News


Miltenyi : New modules to expand processing capabilities of the CliniMACS Prodigy® Platform: electroporation and final formulation

August 05, 2022

The CliniMACS Prodigy represents the next generation in automated cell processing. This device offers advanced integrated solutions to streamline cell processing workflows – from cell separation through cell culture to...

Learn more

Gilson is pleased to partner with Syngoi Technologies to equip their latest GMP facility

August 04, 2022

We are pleased to announce that Gilson Connect solutions have been selected by Syngoi Technologies to enforce the traceability and repeatability of manual protocols. Syngoi Technologies is a biotechnology company...

Learn more

Gilson is pleased to partner with France Blood Transfusion Agency (EFS) Platform for Innovation in Biotherapies

August 03, 2022

Gilson is pleased to announce a new chapter of collaborating with the EFS Gene and Cell engineering unit of Bourgogne Franche Comté. The collaboration provides the EFS Development & Transfer...

Learn more

New automated process to simplify the manufacturing of gene-engineered NK Cells and Treg cells isolation

July 28, 2022

To address the variety of Treg cell applications, Miltenyi Biotec provides a broad range of tools for clinical use.

Learn more

CREAPHARM DEMONSTRATES UNPARALLELED PERFORMANCE OF -80°C NITROGEN TANK TECHNOLOGY

July 28, 2022

CREAPHARM BIOSERVICES has recently invested in -80°C nitrogen tanks to provide Biotechs and Research key players with a new solution to meet the challenges of ultra-low temperature storage.

Learn more

Videodrop, an ideal tool for the monitoring of bioproduction of Viral vectors

July 19, 2022

Today, Gene and Cell therapies are booming. However, due to the lack of solutions allowing rapid & continuous monitoring throughout the bioproduction process, Biotech’ companies are working “almost blind”. They...

Learn more

Measuring Size & concentration of nanoparticles

July 19, 2022

The Videodrop makes it possible to measure the size and concentration of biological nanoparticles like lentivirus, adenovirus or retrovirus

Learn more

Cytiva and Bayer to collaborate on allogeneic cell therapy manufacturing platform

July 12, 2022

Learn more

Article on improving viral vector production in GEN

July 12, 2022

GEN recently interviewed our Business Development Director, Dr. Natalia Elizalde, with whom they spoke about improving the production of lentiviral vectors, vectors that VIVEbiotech develops and manufactures.

Learn more

Cytiva and Nucleus Biologics join forces to accelerate development of custom cell media for cell and gene therapies

July 07, 2022

Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and...

Learn more

PharmaBoardoom points out VIVEbiotech as one of the ten Spanish Biotechs to watch in 2022

July 05, 2022

PharmaBoardroom, a leading British media specialized in the health sector, has published an article in which it highlights VIVEbiotech as one of the ten Spanish biotechs to follow in 2022.

Learn more

The Analytical Scientist interviews Rakel Lopez de Maturana

June 28, 2022

The Analytical Scientist interviewed Rakel Lopez de Maturana, VIVEbiotech´s Qualified Person & Regulatory Affairs Director.

Learn more

Gurutz Linazaroso, the CEO of VIVEbiotech, in the Medicine Maker Power List 2022

June 21, 2022

The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, is part of the prestigious The Medicine Maker Power List.

Learn more

Interview with Natalia Elizalde in The Medicine Maker

June 14, 2022

The Business Development Director of VIVEbiotech Dr. Natalia Elizalde was interviewed by The Medicine Maker on the challenges of lentiviral vector manufacture/use.

Learn more

Plasmid DNA manufacturing – Soon a GMP Grade unit in TEMIS Santé, Besançon – Fr

April 19, 2022

Learn more